ArticleAsian bioethics review2020
Why have Non-communicable Diseases been Left Behind?
Article in Asian bioethics review, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Impact of COVID-19 pandemic on non-communicable diseases care and service deliveries in Sub-Saharan Africa: A systematic review.BMC health services research · 2025Pooled it
- Article
- Using data science to identify climate change and health adverse impacts and solutions in Africa: a scoping review.npj health systems · 2026Article
- Health-seeking behavior and the related out-of-pocket expenditure for noncommunicable diseases in Erbil, Iraq: a quantile regression analysis.Journal of health, population, and nutrition · 2026Article
- Mediterranean diet impact on plasma proteins: biomarker networks linking nutrition to the modulation of inflammation and oxidative stress.Frontiers in nutrition · 2026Review
- Determinants of outpatient healthcare-seeking behaviors among the rural poor affected by chronic conditions in India: a population-based cross-sectional study in seven states.Global health action · 2025Article
- Breast and Cervical Cancer Gaps in Displaced Lebanese Women in Syria.JAMA network open · 2025Article
- "They tossed me up like a ball": informal settlement residents' experiences in accessing healthcare in Kampala, Uganda.BMC public health · 2025Article
- Analysing health conditions and economic influence on healthcare infrastructure: A comparative analysis of India, China, Japan, and South Korea.Journal of family medicine and primary care · 2025Article
- Impact of COVID-19 on the management of hypertension: a perspective on disease severity, service use patterns and expenditures from Ghana's health insurance claims data.Journal of human hypertension · 2025Article
- Towards Implementation of Equitable and Effective Non-Communicable Disease Policies Comment on "Barriers and Opportunities for WHO 'Best Buys' Non-Communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review".International journal of health policy and management · 2025Article
- Disease foci of pharmaceutical research and development as reflected in applications for International Nonproprietary Names, 1953-2022.Bulletin of the World Health Organization · 2025Article
- Multifaceted barriers associated with clinical breast examination in sub-Saharan Africa: A multilevel analytical approach.PloS one · 2025Article
- Access to hypertension services and health-seeking experiences in rural Coastal Kenya: A qualitative study.PLOS global public health · 2025Article
- Variations in out-of-pocket spending and factors influencing catastrophic health expenditure of households with patients suffering from chronic conditions in four districts in Sri Lanka.BMC health services research · 2024Article
- Cost of Care for Non-communicable Diseases: Which Types of Healthcare Providers are the Most Economical in India's Chhattisgarh State?PharmacoEconomics - open · 2024Article
- Out-of-pocket expenditures associated with double disease burden in Pakistan: a quantile regression analysis.BMC public health · 2024Article
- Ethical considerations in prevention and management of non-communicable diseases: a narrative review.Journal of medical ethics and history of medicine · 2024Review
- Predictors of Multimorbidity (Defined as Diabetes + Hypertension) Amongst Males Aged 15-54 in India: An Urban/Rural Split Analysis.International journal of public health · 2024Article
- Progress and challenges in implementing non-communicable disease policies in Sudan.Health research policy and systems · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-communicable diseases are no longer largely limited to high-income countries and the elderly. The burden of non-communicable diseases is rising across all country income categories, in part because these diseases have been relatively overlooked on the global health agenda. Historically, communicable diseases have been prioritized in many countries as they were perceived to constitute the greatest disease burden, especially among vulnerable and poor populations, and strategies for prevention and treatment, which had been successful in high-income settings, were considered feasible and often affordable in low-income settings. This prioritization has reduced the communicable diseases burden globally but has left non-communicable diseases largely neglected. A new approach is urgently needed to tackle non-communicable diseases. Based on an analysis of potential features which may have underlain the different approaches to non-communicable diseases and communicable diseases until now, including acuity of disease, potential for control or cure, cost, infectiousness, blaming of individuals and logistical barriers, little ethical or rational justification can be found to support continued neglect of non-communicable diseases. Justice demands access to quality and affordable care for all. An equitable approach to non-communicable diseases is therefore strongly mandated on medical, ethical, economic, and public health grounds. Funding must not however be diverted away from communicable diseases, which continue to require attention-but concomitantly, funding for non-communicable diseases must be increased. International and multi-sectoral action is required to accelerate progress towards true universal health coverage and towards achievement of all of the sustainable development goals, such that prevention and access to care for non-communicable disease can become a global reality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.